•To design and optimize the CaHA-based biomaterial composition with adjustable rheological properties;

•To conduct in vitro biocompatibility testing;

•To fabricate 3D-printed implants using the material;

•To perform preclinical trials in animal models (paralysis and stenosis);

•To evaluate volume retention and tissue integration.

this is a panel about Vocal fold paresis. When I couldn’t get the patient’s voice back

Objectives: to summarize the current literature for epidemiology, clinical management, and treatment of laryngopharyngeal reflux disease (LPRD).

Methods: Based on a PRISMA systematic search of literature, the author will provide an EBM practice for general otolaryngologists and laryngologists for the management of LPRD. A special focus will be done on the definition of LPRD, the decision to perform objective additional examination (hypopharyngeal-esophageal impedance-pH testing) or empirical therapeutic trial, the method for assessing the treatment responses, and the best therapeutic regimens. At the end of the keynote lecture, the audience should manage primary and recalcitrant LPRD.

In this panel, Salivary control disorders are going to be discuss from diagnosis to the treatment